China’s growing pipeline of novel drug candidates is expected to draw increased attention from global pharmaceutical companies and investors scouting…
Read More »multinational corporations
As we approach 2025, China stands on the brink of a series of transformations. Geopolitical volatility and rising tariffs are…
Read More »Equinix plans to spend US$124 million to build its sixth data centre in Hong Kong, expanding its storage capacity to…
Read More »

